Entropy – based Biomarkers for individualized response on Bosutinib treatment in chronic phase CML - Brummendorf

Tim Brümmendorf

DOI: 10.25934/pr00004921
Published: 2025
Container: Not recorded
Publisher: Vivli
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.25934/pr00004921,
  title = {Entropy – based Biomarkers for individualized response on Bosutinib treatment in chronic phase CML - Brummendorf},
  author = {Tim Brümmendorf},
  year = {2025},
  doi = {10.25934/pr00004921},
  url = {https://doi.org/10.25934/pr00004921}
}

RIS

TY  - JOUR
TI  - Entropy – based Biomarkers for individualized response on Bosutinib treatment in chronic phase CML - Brummendorf
AU  - Tim Brümmendorf
PY  - 2025
DO  - 10.25934/pr00004921
UR  - https://doi.org/10.25934/pr00004921
ER  -

APA

Brümmendorf, T. (2025). Entropy – based Biomarkers for individualized response on Bosutinib treatment in chronic phase CML - Brummendorf. https://doi.org/10.25934/pr00004921

Source records

datacite · retrieved 2026-11-10T07:13:46.933Z